Recent advances in bioreactors for cell-based therapies

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Therapy

Background:

• Bioreactors are vital for controlled cell environments in therapy and research.
• They support cell growth, differentiation, and tissue development.
• Standardized products and in vitro models are key applications.

Purpose of the Study:

• To review the three main classes of bioreactors: cell expansion, tissue engineering, and lab-on-a-chip systems.
• To examine research drivers and recent advancements (last 3 years).
• To discuss emerging issues impacting bioreactor commercialization and clinical use.

Main Methods:

• Literature review of bioreactor advancements.
• Categorization into cell expansion, tissue engineering, and lab-on-a-chip systems.
• Analysis of research trends and commercialization challenges.

Main Results:

• Recent advancements in bioreactor technology have been reported across all three classes.
• Key research drivers include scalability, simplification of in vivo systems, and enhanced control.
• Commercialization hurdles involve scaling up cell quantities, reducing reliance on external factors, and improving miniaturized system monitoring.

Conclusions:

• Bioreactors are indispensable for cell-based therapies and in vitro modeling.
• Continued innovation is needed to address scalability, simplification, and control for clinical and commercial success.
• Future directions focus on optimizing manufacturing and monitoring for complex physiological systems.